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Abstract The high mobility group protein HMG-D is known to
bind preferentially to DNA of irregular structures with little or
no sequence specificity. Upon binding to DNA, this HMG-box
protein widens the minor groove of the double helix and induces a
significant bending of the helix. We show here that HMG-D can
strongly bind to double-stranded RNA. Electrophoretic mobility
shift assays show that HMG-D100 interacts with the transacti-
vation response region (TAR) RNA from HIV-1. Strong
interaction with a high affinity Rev protein binding element
(RBE) RNA was also characterized. Gel shift experiments
performed with several TAR RNA constructs lacking the lateral
pyrimidine bulge or with modified apical loop regions indicate
that the protein does not recognize the single-strand domains of
the RNA but apparently interacts directly with the double-
stranded stem regions. No protein^RNA complexes could be
detected when using single-stranded oligoribonucleotides. HMG-
D protein could bind to the wide minor groove of the A-form
TAR RNA. The comparison of the amino acid sequence of
HMG-D with that of known RNA binding proteins suggests that
the interaction of the protein with a double-stranded RNA
implicates the basic region of HMG-D as well as its HMG-box
domain. From the in vitro data reported here, we propose a novel
functional role for proteins of the HMG-1 family. The results
suggest that architectural HMG proteins can be recruited by
double-stranded RNA for the development of HIV-1 in the host
cell. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The transactivation response region (TAR) RNA sequence
is located at the 5P-end of all nascent HIV-1 transcripts [1,2].
It adopts a hairpin secondary structure consisting of a highly
conservative 6 nucleotide (nt) loop and a 3 nt pyrimidine
bulge (UCU or UUU at positions 23^25) £anked by two
double-stranded stems [3,4] (Fig. 1). The pyrimidine bulge is
essential for high a⁄nity and speci¢c binding to the trans-
activator protein Tat [5]. Currently, it is believed that the
major role of TAR is to act as an RNA enhancer that con-
trols HIV-1 transcription at initiation and elongation. The
functional Tat^TAR interaction in vivo requires cellular co-
factors [6]. Cellular proteins capable of interacting directly
with TAR include RNA polymerase II, the protein kinase
PKR, its antagonist TRBP [7], Pur-K, the nuclear protein
p140 [8], and the translation initiation factor 2, eIF2 [9].
This later protein, as well as TRBP, recognizes the apical
loop of TAR. It is likely that many other proteins are re-
cruited by TAR as the virus must require di¡erent host cell
factors to achieve its speci¢c gene regulation [10]. Identi¢ca-
tion of these proteins is essential for a better understanding of
the mechanism responsible for the development of the virus in
the host cell.
Binding of Tat protein to TAR is mediated by the nine
amino acid region RKKRRQRRR [11^13]. Because similar
Arg/Lys-rich peptide sequences are found in all high mobility
group (HMG) proteins, we postulated that the TAR RNA
could also interact with chromosomal proteins containing a
HMG domain. To test this hypothesis, we chose HMG-D
which is one of the Drosophila melanogaster counterparts of
the abundant chromosomal protein HMG-1 [14,15]. This pro-
tein with a single HMG domain binds to the minor groove of
double-stranded DNA with minimal sequence speci¢city [16],
preferring duplex DNA that is deformable, ‘pre-bent’ and/or
underwound [17,18]. The structure of the free HMG-D pro-
tein in solution shows an L-shaped fold with three K helices
stabilized by two hydrophobic cores [19]. Recently, the X-ray
crystal structure of the HMG domain of HMG-D complexed
with the linear palindromic decamer GCGATATCGC was
solved [20]. Binding of the protein to the minor groove of
the DNA duplex induces a bend of the double helix away
from the protein towards the major groove. The structure
also revealed multiple intercalations and water-mediated
DNA contacts [21]. The structural basis of DNA binding by
HMG proteins is now relatively well understood [22]. In sharp
contrast, to our knowledge, there is as yet no information
available on the potential interaction of HMG proteins with
RNA.
As an initial approach, we report here the results of gel shift
experiments showing that HMG-D binds to the TAR RNA
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hairpin structure. The use of several TAR RNA constructs
and a 57 nt RNA corresponding to the high a⁄nity Rev
protein binding element (RBE), indicates that HMG-D inter-
acts with the double-stranded region of the RNA. The results
suggest that architectural HMG proteins are recruited by
leader RNA for the development of the HIV-1 in the host cell.
2. Materials and methods
2.1. HMG-D protein
HMG-D contains a single HMG domain followed by a basic region
and an acidic tail. In the experiments presented here, we used the
HMG-D100 construct which corresponds to the ¢rst 100 amino acids,
that is the HMG domain plus the basic region but lacking the acidic
tail [17]. The HMG-D100 protein, overproduced in Escherichia coli,
was puri¢ed according to a standard procedure [16]. It was stored at
320‡C in 50 mM HEPES bu¡er pH 7.5 containing 1 mM EDTA and
50% glycerol. All other chemicals were analytical grade reagents, and
solutions were prepared with doubly distilled sterile water to prevent
from nuclease contamination. Tubes and tips were treated with 1x
diethylpyrocarbonate (DEPC from Sigma).
2.2. In vitro transcription of RNA
Synthetic oligonucleotides corresponding to the wild type TAR and
mutated TAR sequences were cloned between HindIII and EcoRI sites
of the pUC19 plasmid. After digestion with EcoRI, the RNA was
transcribed as a run-o¡ product of 60 (wild type TAR and U loop
TAR), 58 (UUCG stable loop TAR) and 57 (vU-TAR) nts from the
T3 RNA polymerase promoter. In each case the transcript includes an
additional G residue on the 3P-end derived from the EcoRI cleavage
site. Transcription reaction was performed in bu¡er containing 40
mM Tris^HCl, pH 7.4, 25 mM NaCl, 16 mM MgCl2, 10 mM DTT
and 1 mM NTPs. The reaction was initiated by the addition of 10 Wg
linearized plasmid DNA template and 40 Wg T3 RNA polymerase and
incubated for 2 h at 37‡C. Nucleic acids were then fractionated on a
10% (w/v) polyacrylamide gel containing 8 M urea in TBE bu¡er (89
mM Tris^borate pH 8.3, 10 mM EDTA). After electrophoresis, the
RNA was eluted in water for 18 h at 4‡C and precipitated with
ethanol. The RNA was resuspended in water to give a 500 WM stock
solution (O260/phosphate = 10 688 M31 cm31). The RNA was 3P-end
labeled with [32P]cytidine biphosphate and T4 RNA ligase and then
repuri¢ed from a 10% denaturing acrylamide gel [13]. The 14 and
17 base oligoribonucleotides were purchased from Genset (Paris)
and puri¢ed on a 15% denaturing acrylamide gel prior to the labelling
with P32. A published procedure was followed to prepare the 57 nt
RBE RNA [23].
2.3. Gel mobility shift assay
Binding reactions (20 Wl) contained the 32P-labeled RNA (2 Wl,
about 15 nM) and varying concentrations of the HMG-D protein in
a TK bu¡er consisting of 10 mM Tris^HCl (pH 7.4), 50 mM NaCl,
1 mM EDTA, 5 mM DTT and 0.1% Triton X-100. Samples were
incubated for at least 10 min on ice prior to the addition of 2 Wl
loading mix and electrophoresis on a 8% non-denaturing polyacryl-
Fig. 1. Sequences and secondary structures of the wild type TAR
RNA and the mutants used in this study. The uridine bulge is miss-
ing in the vU-TAR RNA.
Fig. 2. Electrophoretic mobility shift assay of HMG-D binding to
the TAR RNA at (A) 20‡C or (B) 4‡C. The RNA was 3P-end la-
beled with [32P]cytidine biphosphate and T4 RNA ligase. An esti-
mated 100 pM of 32P-60-nt RNA was titrated with the indicated
concentrations (nM) of the protein. The two HMG^TAR complexes
and free RNA are identi¢ed as c1, c2 and f, respectively. Complexes
were separated from unbound RNA by electrophoresis in non-dena-
turing 8% polyacrylamide gels containing 0.1% Triton X-100 in 1U
TBE bu¡er. C: The binding plots show the concentration depen-
dence for the formation of the c1 and c2 complexes and the decrease
of the unbound RNA form f.
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amide gel containing 0.1% Triton X-100 and 1U TBE bu¡er. After
about 1.5 h electrophoresis at 200 V and at 4‡C, the gel was dried and
analyzed on a Phosphor-imager (Molecular Dynamics).
2.4. RNase A footprinting, gel electrophoresis and data processing
The procedure for the footprinting experiments was adapted from
published protocols [24]. Brie£y, samples of the labelled RNA frag-
ment were incubated with a bu¡ered solution containing the desired
protein concentration. After 20 min incubation at 4‡C to ensure equil-
ibration, the digestion was initiated by addition of the RNase A so-
lution. After 1 min incubation at room temperature, the reaction was
stopped by freeze drying and samples were lyophilized. The RNA in
each tube was resuspended in 5 Wl of formamide^TBE loading bu¡er,
denatured at 90‡C for 4 min then chilled in ice for 4 min prior to
loading on to a 0.3 mm thick, 10% polyacrylamide gel containing 8 M
urea and TBE bu¡er (89 mM Tris base, 89 mM boric acid, 2.5 mM
Na2 EDTA, pH 8.3). After 2 h electrophoresis at 1500 V, the gel was
soaked in 10% acetic acid for 10 min, transferred to Whatman 3MM
paper, dried under vacuum at 80‡C and then analyzed on the phos-
phorimager (Molecular Dynamics). Each resolved band on the auto-
radiograph was assigned to a particular bond within the RNA frag-
ment by comparison of its position relative to sequencing standards
generated by treatment of the RNA with diethylpyrocarbonate fol-
lowed by aniline-induced cleavage at the modi¢ed bases (A track).
3. Results
A simple electrophoretic mobility shift assay was employed
to investigate the interaction of the HMG-D protein with the
wild type TAR RNA prepared by in vitro transcription. Dif-
ferent amounts of puri¢ed protein were incubated with a ¢xed
amount of radiolabeled RNA in a standard binding bu¡er
and the mixture of free and protein-bound RNA was resolved
on a non-denaturing polyacrylamide gel (Fig. 2). We found
that HMG-D forms two complexes with the RNA suggesting
the presence of at least two binding sites within the 60 nt
sequence. The complex containing at least two proteins per
RNA molecule was di⁄cult to visualize when the binding
reaction and electrophoresis were performed at room temper-
ature (Fig. 2A). Lowering the temperature greatly helped to
distinguish the c2 complex but in this case much of the pro-
tein^DNA complexes did not enter the gel for [HMG-D] = 50
nM (Fig. 2B). This ¢rst set of experiments provides direct
evidence that the HMG protein interacts strongly with the
TAR RNA as judged from the formation of protein^DNA
complexes at concentrations as low as 0.3 nM. Several gels
as in Fig. 2B were quantitated by densitometry (Fig. 2C) and
a dissociation constant, Kd of 29 þ 4 nM was determined from
the binding plots.
To identify a potential HMG-D binding site on the TAR
RNA, we probed the RNA and RNA^drug complexes with
RNase A. Since the susceptibility of RNA to attack by RNase
A is dependent on secondary structure rather than on primary
sequence, this enzyme is not the most appropriate nuclease to
monitor protein binding to the two double-stranded stem re-
gions of the RNA. However, this enzyme is particularly well
suited for investigating drug binding to the single strand parts,
including the bulge and loop regions. The cleavage patterns
are shown in Fig. 3. In the presence of 50 nM HMG-D, the
strong cleavage at positions 37^38 is largely reduced whereas
the cutting at position 29 is slightly enhanced. These foot-
printing experiments indicate that the reactivity of the nt res-
idues near the apical loop (CCU at positions 29^31) is appar-
ently not a¡ected by the protein binding but in contrast, the
HMG protein may interact with the CUC 37^39 sequence
opposite the UUU bulge. RNase A detects a concerted change
in the helix conformation as a result of binding of HMG-D to
the TAR RNA. Initially, we interpreted the base protection
e¡ect as being due to direct interaction with the protein but,
on the basis of the subsequent experiments (see below), the
protection could arise from protein-induced structural
changes.
The uridine bulge is an important contributor to the struc-
tural stability of TAR and is absolutely essential for the in-
teraction with the Tat protein [25]. According to the above
footprinting experiments, the uridine bulge may also play an
important role in the binding of HMG-D to the RNA. To
verify this idea, we elaborated an analogue lacking the pyrim-
idine bulge and the resulting 57 nt vU-TAR RNA was used as
a substrate for HMG-D. As shown in Fig. 4A, the deletion of
the UUU bulge does not prevent HMG-D binding to the
RNA. Both the c1 and c2 complexes seen with the wild type
Fig. 3. RNase A footprinting of HMG-D on wild type TAR. The
cleavage products of RNase digestion were resolved on a 10% poly-
acrylamide gel containing 8 M urea. The concentration (WM) of the
protein is shown at the top of the appropriate gel lanes. Control
track labeled ‘Cont’ contained no protein. The vertical black bar re-
fers to the site of reduced RNase A cleavage induced by HMG-D.
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RNA were detected with vU-TAR and the measured dissoci-
ation constant was almost unchanged (Kd = 36 þ 3 nM).
Therefore, the pyrimidine bulge of the TAR RNA is not nec-
essary for HMG-D binding.
Two additional TAR mutants were prepared by in vitro
transcription. Firstly, we substituted the UGGG upper loop
of TAR, which provides a binding site for certain proteins
such as TRBP (7), for a UUUU loop. Howevcer, here again,
the interaction of HMG-D with the RNA was not signi¢-
cantly a¡ected as the two protein^RNA complexes were de-
tected with the same range of protein concentrations (Fig.
4B). Secondly, we replaced the 6 nt upper loop of TAR by
a shorter 4 nt loop. The UUCG tetrad was substituted for the
CUGGGA sequence of TAR. The loop sequence UUCG oc-
curs exceptionally often in ribosomal and other RNAs, and is
believed to serve as a nucleation site for RNA folding and as
a protein recognition site [26]. A hairpin RNA containing this
loop displays unusually high thermodynamic stability and the
structure of the loop was solved by nuclear magnetic reso-
nance [27]. We reasoned that a TAR RNA containing such
a potentially highly stable loop may o¡er a stronger binding
site for HMG-D. The corresponding 58 nt TAR RNA con-
taining the UUCG loop (Fig. 1) was synthesized by in vitro
transcription, radiolabeled and then used as a substrate for
Fig. 5. Electrophoretic mobility shift assay of HMG-D binding to
(A) the U bulge and (B) the linear oligoribonucleotide duplexes (se-
quences shown in Fig. 1). Complexes were separated from unbound
RNA by electrophoresis in non-denaturing 10% polyacrylamide gels
containing 0.1% Triton X-100 at 4‡C. The lower panel (C) shows
that HMG-D does not bind to the 14 bases single-stranded oligori-
bonucleotide. Other details as for Fig. 2.
Fig. 4. Electrophoretic mobility shift assay of HMG-D binding to
the mutants TAR RNA: (A) vU-TAR, (B) U loop TAR and (C)
UUCG stable loop RNA. Complexes were separated from unbound
RNA by electrophoresis in non-denaturing 8% polyacrylamide gels
containing 0.1% Triton X-100 in 1U TBE bu¡er at 4‡C. Other de-
tails as for Fig. 2.
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the gel shift analysis, as with the other 60 nt RNA. The gel
shift presented in Fig. 4C reveals that the HMG-D protein
still interacts strongly with this UUCG containing stable loop
RNA. Two protein^RNA complexes were easily detected and
the measured dissociation constant was identical to that de-
termined with the wild type RNA (Kd = 30 þ 6 nM). Therefore
the replacement of the CUGGGA upper loop of TAR with a
more compact UUCG loop, potentially more stable, has no
signi¢cant e¡ect on the RNA binding of HMG-D. Therefore,
neither the UUU bulge, nor the upper loop is essential to the
binding of HMG-D to the TAR RNA.
We further investigated the interaction between HMG-D
and potential RNA substrates using short synthetic oligoribo-
nucleotides corresponding to the central part of the wild type
TAR sequence. Two radiolabelled RNA duplexes of 14 bp,
with and without a 3 nt bulge, were incubated with HMG-D.
The sequences of the two duplexes are shown in Fig. 1 and the
results of the gel shift experiments are presented in Fig. 5A,B.
In both cases, a single protein^RNA complex was detected,
even when using the linear duplex lacking the bulge. The
interaction of HMG-D with the U bulge duplex (Kd = 53 þ 6
nM) is weaker than with the TAR RNA and deletion of the
UUU triplet further reduces the binding a⁄nity (Kd = 70 þ 10
nM for the linear duplex). However, it is clear that the HMG
protein still interacts strongly with the double-stranded RNA
duplex. No bulge is required but the duplex structure is essen-
tial because we did not detect any protein^RNA complex
when using single-stranded oligoribonucleotides (Fig. 5C). A
14 bp RNA duplex is su⁄cient for HMG-D binding.
Finally, we repeated the binding experiment with another
RNA structure derived from the HIV-1 RBE [28]. The 57 nt
RBE RNA, the sequence and secondary structure is shown in
Fig. 6, was incubated with HMG-D under the same condi-
tions as for the TAR RNA. Again, a strong interaction was
detected and up to three protein^RNA complexes were re-
solved on a non-denaturing polyacrylamide gel (Fig. 6). We
concluded that the interaction of HMG-D with RNA is not
restricted to TAR but can occur with other RNA species, such
as the RBE construct used here and most likely many other
double-stranded RNA sequences.
4. Discussion
HMG-D, the most abundant HMG-1 like chromosomal
protein in Drosophila, has a major role in embryogenesis
when the chromatin is undergoing rapid rounds of replication
[29]. This classical HMG-box protein strongly interacts with
double-stranded DNA with little or no sequence speci¢city. A
slight selectivity for AT-rich sequences containing a TpG/CpA
dinucleotide was deduced from DNase I and binding site se-
lection studies [16]. However, the protein also binds e¡ectively
to DNA sequences lacking a TG step [20]. In addition, HMG-
D exhibits a clear-cut selectivity for deformable and deformed
DNA structures such as four way junctions, cis-platinated
DNA, bulged DNA and DNA containing a disulphide inter-
strand cross-link [17,18,30]. Upon binding to the minor
groove of duplex DNA, HMG-D intercalates one of its me-
thionine residues (Met13) between two consecutive base pairs
and at the same time inserts its Val32 and Thr33 residues into
the DNA two base steps from the intercalation of Met13. This
binding con¢guration induces a substantial bend in the DNA
[20,22,31]. The non-speci¢c binding of HMG-D to double-
stranded DNA is thus well characterized (reviewed in [18]).
In sharp contrast, the interaction of HMG-D with RNA has
never been reported.
As far as we are aware, there is no previous study in the
literature of the possible interaction of HMG1 class of pro-
teins with RNA. This is the ¢rst set of experimental data
indicating that HMG-D has a signi¢cant interaction with
double-stranded RNA structures. The results of the electro-
phoretic mobility shift assays leave no room for doubt that
both the TAR and RBE leader RNA from HIV-1 provide
high a⁄nity binding sites for HMG-D. The experiments per-
formed with several TAR RNA contructs lacking the lateral
pyrimidine bulge or with modi¢ed apical loop regions indicate
that the protein does not recognize the single-strand domains
of the RNA but apparently interacts directly with the double-
stranded stem regions. The exact mechanism of binding re-
mains as yet totally unknown but by analogy with DNA, it is
plausible that the protein recognizes the minor groove archi-
tecture of the double-stranded RNA. The observed lack of
binding of HMG-D to the short single-stranded RNA sequen-
ces indirectly supports this hypothesis. A-type RNA such as
TAR presents a wide minor groove in which the HMG pro-
tein could easily ¢t without need to further open the groove.
With DNA, binding of HMG-D causes signi¢cant distortion
of the double helix backbone leading to an opening of the
minor groove crevice. This process requires much energy for
distortion. In the case of a double-stranded A-form RNA, the
minor groove is already wide and therefore not much energy
is probably needed for the protein to enter the groove. This
could explain, at least in part, why the a⁄nity of HMG-D for
double-stranded RNA is similar to that for DNA. The crystal
structure of the high a⁄nity RBE recently reported reveals the
presence of a non-canonical GWG base pair that is critical in
widening the groove of the duplex RNA for protein binding
and in the overall shape and dimensions of the double helix
[28]. The widening of the groove may thus facilitate binding of
HMG-D. Additional structural studies are warranted to de-
Fig. 6. Electrophoretic mobility shift assay of HMG-D binding to
the RBE RNA. The sequence and primary structure of the 57 nt
RNA is shown. Three complexes marked c1, c2 and c3 were sepa-
rated from unbound RNA by electrophoresis in non-denaturing 8%
polyacrylamide gels containing 0.1% Triton X-100 at 4‡C. Other de-
tails as for Fig. 2.
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limit precisely the mode of interaction between double-
stranded RNA and HMG-D (and probably related HMG-1
type proteins), as well as the consequences of this interaction
in terms of structures and functions. This study opens a com-
pletely new avenue for HMG proteins.
The experiments presented in this study were all performed
with puri¢ed RNA species prepared by in vitro transcription
and use the truncated HMG-D100 protein lacking the 12 res-
idue acidic tail of the full length HMG-D. This C-terminal
domain is known to decrease the a⁄nity of HMG-D for linear
DNA and confers selectivity for deformed DNA structures
[17]. The same trend may apply in the RNA context. Here
we show that HMG-D100 has strong interactions with the
duplex regions of TAR; it is possible that the full length
protein rather prefers the more distorted regions of the
RNA. This question is open to experimental probing.
Another key question concerns the relevance of this in vitro
study. Do the binding of HMG-D to duplex RNA occur in
vivo? This is of course an essential point to address but at
present there are reasons to believe that this interaction can
take place in cells. Bianchi et al. have reported that HMG-1
protein is not stably associated with the chromosomes of so-
matic cells [32]. This protein appears to be uniformly distrib-
uted in the cell nucleus. Apart from their well recognized
architectural roles at the DNA level, HMG-1 proteins could
act as copartner for polymerases and other proteins acting
during transcription. There are several examples of proteins
which interact with both double-stranded DNA and RNA,
such as TFIIIA. This is also the case for histone proteins
[33]. The eukaryotic Y-box proteins [34] also bind both
RNA and DNA but in this case the single-stranded form is
the preferred ligand. Double-stranded RNA binding proteins
such as p68 kinase [35] usually contain scattered basic (both
Arg and Lys) amino acids which are essential for RNA rec-
ognition [36]. HMG-D contains a stretch of basic amino acids
commonly found in known RNA binding proteins including
Tat and Rev. The basic region of HMG-D (amino acids 80^
100) £anking the HMG domain presents a noticeable degree
of similarity with the RNA binding domain of Tat. The se-
quence KKRAKPAKKVAKKSKK (from amino acid posi-
tions 85^100) closely resembles the Arg/Lys sequence found
in the 55^70 region of Tat (30.8% identity in a 13 amino acid
overlap). Moreover, the underlined sequence in HMG-D is
analogous to the basic motif KKLAKRN which represents
the essential part of the TAR RNA binding domain of the
TRBP protein [7]. Similar Arg/Lys peptides also form com-
plexes with TAR [37]. A posteriori, it is therefore not entirely
surprising to observe complex formation between HMG-D
and the TAR RNA. The interaction of the protein with a
double-stranded RNA may implicate the basic region of
HMG-D as well as its HMG-box domain. Continued bio-
chemical and structural analyses will tell us how the HMG-
D protein interacts with duplex RNA and, hopefully, will
allow us to increase our understanding of the functional
role of this previously unexpected and newly discovered inter-
action. Finally, the results also suggest that HMG-1 type pro-
teins may be recruited by the HIV-1 via its leader RNA.
Binding of HMG proteins to the TAR element of HIV
mRNAs may in£uence Tat-mediated activation. The virus
likely needs architectural proteins such as HMG-1 in order
to fully exploit the cell machinery to replicate into infected
cells.
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